Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2/3 Eficacy Study of the AO Pediatric Classification in Treatment and Prognosis of Long Bones Fractures

NCT00533130 is registered in ClinicalTrials.gov with Hospital Cruz Roja Mexicana as lead sponsor.

NCT NCT00533130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00533130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2/3 Eficacy Study of the AO Pediatric Classification in Treatment and Prognosis of Long Bones Fractures
Lead sponsor
Hospital Cruz Roja Mexicana
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2007
Completion date
July 31, 2008
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

children, fractures